Sialic acid residue on host epithelial cell

Sialic acid residues are a diverse family of nine-carbon acidic sugars (commonly N-acetylneuraminic acid/Neu5Ac or N-glycolylneuraminic acid/Neu5Gc) that cap the ends of glycan chains on glycoproteins and glycolipids on the surfaces of all vertebrate cells, including epithelial cells[3][4][1]. They are not receptors or single protein/gene targets, but rather serve as molecular markers and ligands for endogenous lectins (such as Siglecs and selectins) and exogenous agents (bacteria, viruses)[4][5]. Sialic acids regulate membrane stability, cell hydration, cell-cell communication, masking of underlying antigens, and modulate immune and pathogen interactions. Pathogens such as influenza and some coronaviruses specifically recognize sialic acid residues on epithelial cells to initiate infection, while altered cell-surface sialylation contributes to cancer progression and immune evasion. Functionally, sialic acid residues are sites of enzymatic modification by sialyltransferases (adding sialic acid) and neuraminidases/sialidases (removing sialic acid), affecting the cell's biological behaviour and interactions[1]. They are not considered canonical therapeutic targets themselves but are critical for the mechanism of pathogen entry and as disease biomarkers. The term “Sialic acid residues on host epithelial cells” is a structural/glycan feature, not a discrete molecular entity or receptor, and therefore not a canonical therapeutic target.

Other names

Sialic acidSialyl residueTerminal sialic acidSialoglycanSialylated glycan

Blockage/prevention of sialic acid cleavage to inhibit viral release (as with neuraminidase inhibitors) Blocking sialic acid-binding by microbial lectins to inhibit infection (under investigation) Antibody- or lectin-based targeting of sialylation (therapeutic antibodies in development aiming to modulate tumor sialylation)